NASDAQ:BSEM Biostem Technologies Q3 2026 Earnings Date & Estimates $1.15 0.00 (0.00%) Closing price 11/4/2026 04:00 PM EasternExtended Trading$1.15 0.00 (0.00%) As of 11/4/2026 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Biostem Technologies is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 12, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Biostem Technologies in Q3 2026Biostem Technologies is expected to post earnings of -$0.43 per share on revenue of $7.17 million. In the same quarter a year earlier Biostem Technologies reported $0.03 per share on revenue of $10.47 million. Biostem Technologies last reported on August 12, 2026, posting -$0.52 per share and missing the -$0.50 consensus estimate. Biostem Technologies has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.43Expected Revenue$7.17 millionPrior-Year EPS$0.03Prior-Year Revenue$10.47 millionExpected EPS Growth-1,533.3%Expected Revenue Growth-31.6%Recent Track RecordLast ReportedAug 12, 2026Last Quarter EPS-$0.52 (Missed by -$0.02)Last Quarter Revenue$7.90 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileAug 2026 Earnings ReportQ1 2026 Earnings ReportQ3 2025 Earnings Report Biostem Technologies Q3 2026 Earnings FAQ When does Biostem Technologies report Q3 2026 earnings? Biostem Technologies (NASDAQ:BSEM) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Biostem Technologies' Q3 2026 earnings call? Biostem Technologies' Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Biostem Technologies? Analysts expect Biostem Technologies to post earnings of -$0.43 per share for Q3 2026. How much revenue is Biostem Technologies expected to report? The consensus revenue estimate for Biostem Technologies is $7.17 million for Q3 2026. Biostem Technologies Earnings HeadlinesBioStem Technologies (BSEM) AI Stock AnalysisNovember 3 at 1:56 AM | tipranks.comBioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026October 29, 2026 | globenewswire.comDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall. The free download walks through strategies for navigating the options market, but the window to claim it is closing soon.November 5 at 1:00 AM | TradeWins (Ad)Biostem Technologies, Inc. (NASDAQ:BSEM) Sees Significant Growth in Short InterestOctober 29, 2026 | americanbankingnews.comBioStem Technologies’ CEO and COO invest $1M in cash through exercise of stock optionsOctober 8, 2026 | msn.comBioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock OptionsOctober 8, 2026 | markets.businessinsider.comSee More Biostem Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Biostem Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biostem Technologies and other key companies, straight to your email. Email Address About Biostem TechnologiesBiostem Technologies (NASDAQ:BSEM) is a biotechnology company focused on regenerative medicine and biologic tissue products. The company develops, manufactures and commercializes human tissue allografts intended to support wound care, tissue repair and other medical applications. Its product portfolio includes placental- and birth-tissue-derived products, such as amniotic membrane and umbilical cord allografts. These products are marketed for use by healthcare providers in areas including wound management, surgical procedures and related regenerative-care applications. BioStem Technologies serves the U.S. healthcare market through direct and distributor-based sales channels. The company’s operations are primarily focused on advancing and commercializing regenerative medicine products rather than developing conventional pharmaceutical therapies.View Biostem Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?Advanced Micro Devices' Q3 Results Answer a Big Question, But Another Remains3 Dividend Increases Above 10%, But Which Offers the Most Income?High Voltage Returns: Talen Energy Powers the Data Center RushBloom Energy: The Off-Grid Answer to AI's Power DrainWhy ExxonMobil and Chevron Reminded Investors to Keep it SimpleEnergy Transfer's Earnings Miss May Be Hiding Its Strongest Advantage Upcoming Earnings Enbridge (11/6/2026)Brookfield Asset Management (11/6/2026)Humana (11/6/2026)Moderna (11/6/2026)Occidental Petroleum (11/9/2026)KKR & Co. Inc. (11/9/2026)Barrick Mining (11/9/2026)Constellation Energy (11/9/2026)Petroleo Brasileiro S.A.- Petrobras (11/10/2026)Transdigm Group (11/10/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
